EPZM - Epizyme +2.6% as Morgan Stanley joins other bulls December, 05 2019 05:52 PM Epizyme Inc. Epizyme (NASDAQ:EPZM) is up 2.6% postmarket after its last cautious analyst holdout joined others in the bull column.More news on: Epizyme, Inc., Healthcare stocks news, Stocks on the move, Read more ...